HP 228: TRGA began a double-blind, placebo-controlled Phase II dose-escalation trial

Trega Biosciences Inc. (TRGA), San Diego, Calif.

Read the full 74 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE